课题基金 / 基金详情

Tim-4通过LKB1调控巨噬细胞线粒体稳态参与肥胖的作用研究

批准号:
81971480
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
高立芬
依托单位:
学科分类:
免疫调节异常
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
高立芬

项目摘要

结项摘要

项目成果

高立芬的其他基金

相似基金

相关文献

中文摘要
肥胖是慢性低度炎症的病理状态。脂肪组织巨噬细胞(ATMs)是代谢炎症及肥胖发生的关键因素,线粒体代谢可重塑ATMs并控制肥胖进程。免疫调节分子Tim-4高表达于巨噬细胞,参与多种免疫性疾病,申请者前期发现肥胖小鼠ATMs表达Tim-4升高,但Tim-4在巨噬细胞代谢重编程及肥胖中的作用未见报道。近期发现巨噬细胞敲除Tim-4加重高脂诱导的肥胖,RNA-Seq等显示Tim-4敲除使巨噬细胞线粒体基因表达降低及功能受损,促进巨噬细胞向M1极化,质谱提示Tim-4与LKB1结合,干预该通路影响Tim-4对巨噬细胞的调节,进而提出Tim-4经LKB1调控线粒体重塑巨噬细胞参与肥胖的假说。本研究拟利用Tim-4及LKB1敲除等多种工具小鼠,系统研究Tim-4与LKB1互作调控巨噬细胞的机制及在肥胖中的作用。研究的开展有望解析ATMs稳态的调控机制,揭示Tim-4新型生物学功能,为肥胖干预提供新靶点。
英文摘要
Obesity is a serious health problem characterized by execessive expansion of the white adipose tissue coupled with a state of chronic, low-grade inflammation. Obesity-associated inflammation occurs as a result of immune cell infiltration, especially macrophage recruitment and activation in the adipose tissue and increased production of pro-inflammatory cytokines. Adipose tissue macrophages (ATMs) are responsible for obesity metabolic inflammation and insulin resistance. Mitochondrial metabolism reprograms ATMs and determines obesity consequences. Immunoregulator Tim-4 is selectively highly expressed on macrophages and involves in multiple immune diseases. We have found that obesity microenvironments induce Tim-4 expression on ATMs. However, the role of Tim-4 in metabolic reprogramming of macrophages and obesity remains unclear. Recently, we found that specific Tim-4 knockout in macrophages aggravated obesity induced by high fat diet. RNA-sequence, flow cytometry and qPCR assays showed that Tim-4 knockout led to decreased expression of mitochondrial genes and mitochondrial dysfunction, as well as M1 polarization of macrophages. Mass spectrometry,Co-IP and confocal imaging assays inidicated that Tim-4 interacted with LKB1. Intervention of LKB1 pathway affected Tim-4 mediated regulation on macrophages. Based on these data, we put forward the hypothesis that Tim-4 involves in obesity through regulating mitochondrial homeostasis and reprogramming macrophages via LKB1. In this study, Tim-4 and LKB1 conditional knockout mice and other tools would be used to investigate the key role of Tim-4 and LKB1 crosstalk in modulating macrophages and obesity. The accomplishment of this proposal is expected to clarify the regulatory mechanism of ATMs homeostasis, reveal the novel biological function of Tim-4 and provide the new candidate target for obesity intervention.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI: 10.3389/fimmu.2020.00537
发表时间: 2020
期刊: Frontiers in Immunology
影响因子: 7.3
作者: [Wen Liu, Liyun Xu, Xiaohong Liang, Xiaojun Liu, Yangbing Zhao, Chunhong Ma, Lifen Gao]
通讯作者: Lifen Gao
DOI: 10.3389/fimmu.2021.708978
发表时间: 2021
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Xu L, Liu W, Bai F, Xu Y, Liang X, Ma C, Gao L]
通讯作者: Gao L
DOI: 10.1038/s41419-023-05678-3
发表时间: 2023-02-20
期刊: CELL DEATH & DISEASE
影响因子: 9
作者: [Wang, Yuzhen, Wang, Yingchun, Liu, Wen, Ding, Lu, Zhang, Xiaodi, Wang, Bo, Tong, Zheng, Yue, Xuetian, Li, Chunyang, Xu, Liyun, Wu, Zhuanchang, Liang, Xiaohong, Ma, Chunhong, Gao, Lifen]
通讯作者: Gao, Lifen
DOI: 10.3389/fonc.2022.730530
发表时间: 2022
期刊: Frontiers in oncology
影响因子: 4.7
作者: []
通讯作者:
8
    尿石素A结合ERK诱导线粒体自噬增强CAR-T细胞记忆表型和抗肿瘤效应的机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      高立芬
    • 依托单位:
    异位表达于肝细胞的Tim-4负调控NLRP3炎性体参与NAFLD的作用研究
    • 批准号:
      81670520
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2016
    • 负责人:
      高立芬
    • 依托单位:
    乙型肝炎病毒激活NLRP3炎性体致肝损伤的作用研究
    • 批准号:
      81371831
    • 项目类别:
      面上项目
    • 资助金额:
      70.0万元
    • 批准年份:
      2013
    • 负责人:
      高立芬
    • 依托单位:
    Tim-3调节巨噬细胞介导的炎症反应在动脉粥样硬化发生发展中的作用
    • 批准号:
      81100203
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2011
    • 负责人:
      高立芬
    • 依托单位:
    国内基金
    海外基金